Kesar India Limited has submitted its monitoring agency report for the quarter ended December 31, 2025, detailing the utilization of proceeds from its preferential issue under SEBI regulations. The report, prepared by CRISIL Ratings Limited, confirms that the company's fund utilization remains aligned with the disclosed objectives.

Issue Details and Revised Proceeds

The preferential issue was conducted from September 06, 2025 to September 20, 2025, comprising fully convertible warrants and equity shares. The issue size was revised to ₹273.72 crore from the originally planned ₹291.72 crore due to undersubscription of warrants.

Fund Utilization Progress

During the quarter ended December 31, 2025, the company utilized ₹64.97 crore out of the total received proceeds. The cumulative utilization reached ₹107.69 crore by the end of the quarter.

Deployment of Unutilized Funds

The company has deployed its unutilized proceeds in fixed deposits and monitoring accounts to ensure optimal returns while maintaining liquidity. As of December 31, 2025, ₹46.98 crore was invested in various instruments.

General Corporate Purpose Utilization

The company utilized ₹20.19 crore during the quarter for general corporate purposes, which included:

• Repayment of loans: ₹20.00 crore (adjustment against Punjab National Bank and HDFC bank overdraft facilities)
• Payment to BSE Limited: ₹0.13 crore (listing fees)
• Loan to subsidiary: ₹0.05 crore (Kesar Naturals Private Limited)
• Consultancy fees and other expenses: ₹0.01 crore

Monitoring Agency Confirmation

CRISIL Ratings Limited, serving as the monitoring agency, confirmed that there were no deviations from the disclosed objects and that all utilization was as per the disclosures made in the Notice to Shareholders dated August 06, 2025. The agency noted that the company has utilized proceeds towards advance payment for land acquisition and land development through its subsidiary.

The monitoring agency report indicates that ₹119.05 crore, representing 75% of the warrants issue price, is expected to be received within 18 months from the date of allotment upon exercise of conversion rights by warrant holders.

Kesar India Limited has announced that its Board of Directors will convene on February 6, 2026, to review and approve the company's quarterly financial performance. The meeting has been scheduled in accordance with regulatory requirements under SEBI's listing obligations framework.

Board Meeting Details

The upcoming board meeting will focus on several key agenda items related to the company's financial disclosure obligations:

Regulatory Compliance Framework

The board meeting announcement follows strict adherence to Regulation 29 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory framework ensures transparency and timely disclosure of material information to stakeholders and market participants.

Trading Window Restrictions

Kesar India Limited has implemented comprehensive trading restrictions as part of its insider trading prevention measures. The company's designated persons are subject to specific trading limitations during sensitive periods:

These restrictions align with the company's commitment to preventing insider trading and maintaining market integrity during periods when material non-public information may be available to certain individuals within the organization.

Corporate Information

The announcement was signed by Sachin Gopal Gupta, Managing Director (DIN: 07289877), and digitally authenticated on January 30, 2026. Kesar India Limited, formerly known as Kesar India Private Limited and Kesar Impex (India) Private Limited, operates under CIN L51220MH2003PLC142989 with its registered office located in Nagpur, Maharashtra.